Belvarafenib in Combination With Cobimetinib in Patients With Locally Advanced or Metastatic NRAS-Mutant Melanoma

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(10 sites)

South Korea

Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do

Chonnam National University Hwasun Hospital, Hwasun, Jeollanam-do

Dong-A University Medical Center, Busan

Kyungpook National University Chilgok Hospital, Daegu

Chungnam National University Hospital, Daejeon

Seoul National University Hospital, Seoul

Severance Hospital, Seoul

Asan Medical Center, Seoul

Samsung Medical Center, Seoul

Korea University Guro Hospital, Seoul